NI201300052A - COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR - Google Patents

COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR

Info

Publication number
NI201300052A
NI201300052A NI201300052A NI201300052A NI201300052A NI 201300052 A NI201300052 A NI 201300052A NI 201300052 A NI201300052 A NI 201300052A NI 201300052 A NI201300052 A NI 201300052A NI 201300052 A NI201300052 A NI 201300052A
Authority
NI
Nicaragua
Prior art keywords
inhibitor
methods
compositions
treat cancer
mek
Prior art date
Application number
NI201300052A
Other languages
Spanish (es)
Inventor
Debussche Laurent
Garcia-Echeverria Carlos
Ma Jianguo
Mcmillan Stuart
Anne Maurer Ogden Janet
Vincent Loic
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NI201300052A publication Critical patent/NI201300052A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan procedimientos para tratar pacientes con cáncer, en donde los procedimientos comprenden administrar al paciente una cantidad eficaz de un inhibidor de MEK y una cantidad eficaz de un inhibidor de PI3K. También se describen composiciones en las que los inhibidores de MEK y de PI3K están en combinación.Methods of treating cancer patients are provided, wherein the methods comprise administering to the patient an effective amount of a MEK inhibitor and an effective amount of a PI3K inhibitor. Compositions in which the MEK and PI3K inhibitors are in combination are also described.

NI201300052A 2010-12-09 2013-06-07 COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR NI201300052A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42146510P 2010-12-09 2010-12-09
US201161436258P 2011-01-26 2011-01-26
US201161467485P 2011-03-25 2011-03-25
FR1159940 2011-11-03

Publications (1)

Publication Number Publication Date
NI201300052A true NI201300052A (en) 2013-11-12

Family

ID=70471655

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201300052A NI201300052A (en) 2010-12-09 2013-06-07 COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR

Country Status (1)

Country Link
NI (1) NI201300052A (en)

Similar Documents

Publication Publication Date Title
DOP2013000131A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
ZA202208792B (en) Methods of treating and preventing graft versus host disease
GT201300320A (en) COMBINATION THERAPY INCLUDING A CDK4 / 6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN CANCER TREATMENT.
CO6531463A2 (en) COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR
ECSP099376A (en) AKT ACTIVITY INHIBITORS
CO6761389A2 (en) Nampt and rock inhibitors
NI201400109A (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
NI201200090A (en) COMPOSITIONS TO TREAT NAUSEA AND VOMITING CENTRALLY MIDDLE
NI201400111A (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS
NI201500055A (en) TREATMENT OF PROSTATE CANCER WITH TOR KINASE INHIBITORS
UY33221A (en) METHODS TO TREAT CANCER USING PI3K AND mTOR INHIBITORS IN COMBINATION WITH AUTOPHAGIA INHIBITORS
MX2019013862A (en) Combination therapy.
GT201400038A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING THE P13KBETA INHIBITOR AND THE MAPK ROAD INHIBITOR, INCLUDING MEK AND RAF INHIBITORS
ECSP13012988A (en) DERIVATIVES OF TIENOPIRIMIDINE (2,3-D) AND ITS USE TO TREAT ARRITMIA
DOP2014000221A (en) METHODS TO TREAT CANCER USING PI3K INHIBITOR AND MEK INHIBITOR
UY35033A (en) FORMULATION IN TABLETS OF A 3-CINASA PHOSPHYTIDYLINOSITOL INHIBITOR
NI201300052A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
CO6721062A2 (en) Cmpositions and methods to treat cancer using a pi3k inhibitor and a mek inhibitor
ECSP13012736A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
GT201300148A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR
TN2013000247A1 (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer
DOP2009000132A (en) AKT ACTIVITY INHIBITORS